ResMed (RMD) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free RMD Stock Alerts $218.57 -1.40 (-0.64%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability ResMed Short Interest DataCurrent Short Volume9,850,000 sharesPrevious Short Volume7,950,000 sharesChange Vs. Previous Month+23.90%Dollar Volume Sold Short$2.11 billionShort Interest Ratio / Days to Cover9.0Last Record DateApril 30, 2024Outstanding Shares146,910,000 sharesPercentage of Shares Shorted6.70%Today's Trading Volume450,413 sharesAverage Trading Volume1,198,189 sharesToday's Volume Vs. Average38% Short Selling ResMed ? Sign up to receive the latest short interest report for ResMed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRMD Short Interest Over TimeRMD Days to Cover Over TimeRMD Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. ResMed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,850,000 shares $2.11 billion +23.9%N/A9 $214.04 4/15/20247,950,000 shares $1.47 billion +0.8%N/A7.5 $185.09 3/31/20247,890,000 shares $1.56 billion +3.0%N/A7.8 $198.03 3/15/20247,660,000 shares $1.46 billion +13.3%N/A7.9 $190.10 2/29/20246,760,000 shares $1.17 billion +2.7%N/A7.4 $173.72 2/15/20246,580,000 shares $1.20 billion +4.0%N/A7.4 $182.64 Get the Latest News and Ratings for RMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,330,000 shares $1.20 billion +7.5%N/A6.5 $190.20 1/15/20245,890,000 shares $1.02 billion +3.9%N/A5.5 $173.90 12/31/20235,670,000 shares $975.35 million -2.4%N/A4.8 $172.02 12/15/20235,810,000 shares $982.18 million -0.7%N/A4.4 $169.05 11/30/20235,850,000 shares $922.72 million -7.3%N/A3.9 $157.73 11/15/20236,310,000 shares $960.07 million +10.3%N/A3.9 $152.15 10/31/20235,720,000 shares $807.78 million +18.4%N/A3.3 $141.22 10/15/20234,830,000 shares $677.41 million +1.5%N/A2.9 $140.25 9/30/20234,760,000 shares $703.86 million +24.6%N/A3.2 $147.87 9/15/20233,820,000 shares $555.39 million +20.9%N/A2.9 $145.39 8/31/20233,160,000 shares $504.30 million +110.7%N/A2.8 $159.59 8/15/20231,500,000 shares $275.03 million +19.1%N/A1.6 $183.35 7/31/20231,260,000 shares $280.16 million -5.3%N/A1.7 $222.35 7/15/20231,330,000 shares $295.73 million +11.8%N/A2.1 $222.35 6/30/20231,190,000 shares $260.02 million +15.5%N/A1.9 $218.50 6/15/20231,030,000 shares $225.42 million -28.5%N/A1.7 $218.85 5/31/20231,440,000 shares $303.54 million +38.5%N/A2.4 $210.79 5/15/20231,040,000 shares $241.79 million +2.0%N/A1.9 $232.49 4/30/20231,020,000 shares $245.78 million -11.3%N/A1.8 $240.96 4/15/20231,150,000 shares $258.24 million -19.0%N/A2 $224.56 3/31/20231,420,000 shares $310.97 million +9.2%1.0%2.3 $218.99 3/15/20231,300,000 shares $270.39 million +20.4%0.9%2 $207.99 2/28/20231,080,000 shares $230.04 million +1.9%0.7%1.7 $213.00 2/15/20231,060,000 shares $227.77 million +25.5%0.7%1.7 $214.88 1/31/2023844,900 shares $192.95 million -0.6%0.6%1.5 $228.37 1/15/2023850,000 shares $185.39 million -15.8%0.6%1.5 $218.10 12/30/20221,010,000 shares $210.21 million +6.3%0.7%1.8 $208.13 12/15/2022950,100 shares $204.31 million -5.9%0.7%1.8 $215.04 11/30/20221,010,000 shares $232.50 million -5.6%0.7%2 $230.20 11/15/20221,070,000 shares $239.28 million -18.3%0.7%2.2 $223.63 10/31/20221,310,000 shares $293.03 million +6.5%0.9%2.6 $223.69 10/15/20221,230,000 shares $260.45 million -8.2%0.9%2.6 $211.75 9/30/20221,340,000 shares $292.52 million -11.3%0.9%2.9 $218.30 9/15/20221,510,000 shares $341.18 million +18.0%1.0%3 $225.95The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. RMD Short Interest - Frequently Asked Questions What is ResMed's current short interest? Short interest is the volume of ResMed shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 9,850,000 shares of RMD short. Learn More on ResMed's current short interest. What is a good short interest ratio for ResMed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RMD shares currently have a short interest ratio of 9.0. Learn More on ResMed's short interest ratio. Which institutional investors are shorting ResMed? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ResMed: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., and Caas Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ResMed's short interest increasing or decreasing? ResMed saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 9,850,000 shares, an increase of 23.9% from the previous total of 7,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ResMed's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to ResMed: Baxter International Inc. (1.97%), DexCom, Inc. (2.79%), Insulet Co. (4.20%), Teleflex Incorporated (1.25%), Globus Medical, Inc. (6.64%), Becton, Dickinson and Company (0.75%), Boston Scientific Co. (0.95%), Stryker Co. (1.19%), West Pharmaceutical Services, Inc. (1.44%), Shockwave Medical, Inc. (4.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ResMed stock? Short selling RMD is an investing strategy that aims to generate trading profit from ResMed as its price is falling. RMD shares are trading down $1.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ResMed? A short squeeze for ResMed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RMD, which in turn drives the price of the stock up even further. How often is ResMed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RMD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Baxter International Short Interest Data DexCom Short Interest Data Insulet Short Interest Data Teleflex Short Interest Data Globus Medical Short Interest Data Becton, Dickinson and Company Short Interest Data Boston Scientific Short Interest Data Stryker Short Interest Data West Pharmaceutical Services Short Interest Data Shockwave Medical Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:RMD) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA once-in-a-century investment opportunityStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings